Clinical Trials Sponsored by Blokhin's Russian Cancer Research Center

Total 9752 results

H. Lee Moffitt Cancer Center and Research Institute

Completed

Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx

Breast Cancer

United States
Southwestern Regional Medical Center
Gateway for Cancer Research

Completed

Prayer as a Possible Adjuvant Treatment for Breast Cancer

Breast Neoplasms

United States
Trinitas Comprehensive Cancer Center
Aptium Oncology Research Network

Unknown

Guided Relaxation Training for the Reduction of Self-Reported Stress in Individuals With Newly Diagnosed Breast Cancer (09-IM-01)

Breast Cancer

United States
Ludwig Institute for Cancer Research
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; New York...

Completed

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Sarcoma | Esophageal Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer

United States
National Cancer Centre, Singapore
National Cancer Centre Research Fund

Recruiting

Somatostatin Receptor Imaging in NPC, EBV Related Cancers

Nasopharyngeal Cancer | Epstein-Barr Virus Related Carcinoma

Singapore
National Research Center - Institute of Immunology...

Completed

Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19

COVID-19

Russian Federation
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

Lung Cancer | Non Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Non-Invasive Biomarkers in Prostate Cancer Disease Management

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

Oropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | Hypopharynx Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

Lynch Syndrome | Pancreatic Ductal Adenocarcinoma | Chronic Pancreatitis | Pancreatic Cyst | Ataxia Telangiectasia | FAP | Peutz-Jeghers Syndrome | PALB2 Gene Mutation | BRCA Mutation | Fatty Pancreas | Genetic Pancreatic Cancer | Genetic Pancreatitis | Familial Atypical Multiple Mole-Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Wet Heparinized Suction for Abdominal Cancer (EUS Heparin)

Cancer | Cancer of Liver | Cancer of Pancreas | Cancer of Stomach | Cancer of Esophagus

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Hodgkin Lymphoma | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Lymphoplasmacytic Lymphoma | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Myeloproliferative Neoplasm | Relapsed Follicular Lymphoma | Relapsed T-Cell Lymphoma and other conditions

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

STRONG Program for Cancer Patients

Gastrointestinal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

Myelodysplastic Syndromes | Secondary Acute Myeloid Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Mesothelioma | Malignant Pleural Mesothelioma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

Oropharyngeal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

Metastatic Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

Smoking | Tobacco Use | Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Glioma of Brain

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

HPV Vaccine | HPV

United States, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute

Completed

Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance

Sleep Disturbance

United States, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute

Completed

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

Squamous Cell Carcinoma of the Head and Neck

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Carcinoma, Squamous Cell | Squamous Cell Carcinoma of Skin

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Myelodysplastic Syndromes | Primary Myelofibrosis | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelomonocytic Leukemia | Chronic Myeloid Leukemia | Acute Leukemia in Remission

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Fermented Wheat Germ Extract in Women With Ovarian Cancer

Ovarian Cancer

United States
Institut Paoli-Calmettes
Cancer Research Center of Marseille

Unknown

ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia (CeGAL)

Leukemia, Myeloid, Acute

France
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Biomarker Correlates of Hypoxia in Metastatic Melanoma

Melanoma | Skin Cancer
Princess Al-Johara Al-Ibrahim Cancer Research Center

Completed

Escalating, Constant and Reduction Energy Output in SWL for Renal Stones (SWL)

Renal Stones

Saudi Arabia
H. Lee Moffitt Cancer Center and Research Institute

Completed

Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

Acute Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

The Human Papillomavirus (HPV) Transmission Pilot Study

Human Papillomavirus Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Phase II Trial of Pentostatin and Targeted Busulfan (Pento & tBU)

Hematologic Malignancies

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess

Cancer | Cancer Screening Patients | Patient Volunteers

United States
Stanford University
University of Hawaii Cancer Research Center

Completed

Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors

Neoplasms | Breast Cancer | Prostatic Neoplasms | Colorectal Neoplasms | Blood Cancer

United States, United Kingdom
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Samsung Medical Center
Korean Foundation for Cancer Research

Unknown

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Lung Adenocarcinoma

Korea, Republic of
Dattoli Cancer Center and Brachytherapy Research...
Sanofi

Completed

Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis

Prostate Cancer Patients Undergoing External Radiation and Seed Implantation

United States
H. Lee Moffitt Cancer Center and Research Institute
Patient-Centered Outcomes Research Institute

Completed

Navigator Guided e-Psychoeducational Intervention

Prostate Cancer

United States
German Cancer Research Center
German Research Foundation; Wuerzburg University Hospital; Baden-Württemberg...

Recruiting

Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project)

Cancer-related Fatigue

Germany
National Research Center for Preventive Medicine
The League of Clinical Research, Russia

Completed

Primary Prevention Program (3P)

Primary Prevention of Cardiovascular Disease

Russian Federation
Abramson Cancer Center at Penn Medicine
Patient-Centered Outcomes Research Institute

Active, not recruiting

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

Breast Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Cancer Prevention Research Institute of Texas

Recruiting

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

Smoking | Lung Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Cancer Prevention Research Institute of Texas

Completed

Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

Lymphoma | Leukemia

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
The John P. Hussman Foundation

Completed

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Melanoma

United States

Clinical Trials Sponsored by Blokhin's Russian Cancer Research Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations